IN REVIEW
Glaucoma and neuro-ophthalmology intersect at clinical conference Biennial Glaucoma and Neuro-ophthalmology Fall Festivals September 23-25, 2016 | Boston Co-directors: Louis Pasquale, MD; Joseph Rizzo III, MD; and Angela Turalba, MD
M
Left to right: Joseph Rizzo III, MD; Angela Turalba, MD; Louis Pasquale, MD; Mark Moster, MD; and Marlene Moster, MD
ore than 120 clinicians, scientists, and trainees attended three days of surgical and clinical case presentations, topical lectures, and interactive panel discussions pertaining to glaucoma and neuro-ophthalmology at the Biennial Glaucoma and Neuro-ophthalmology Fall Festivals. Helen Danesh-Meyer, MD, PhD, University of Auckland, New Zealand, presented the keynote lecture, The crossroad between glaucoma and neuro-ophthalmic disease, which served as a bridge between the day of glaucoma sessions and subsequent neuro-ophthalmology sessions. Attendees highlighted the value of the dual glaucoma and neuro-ophthalmology focus: • I re-learned the importance of taking a thorough and accurate patient history. • The course assured me that a neuro-ophthalmology referral is appropriate when a patient’s symptoms do not match the appearance of the cataract. • I plan to use color vision testing and field testing on any unexplained visual disturbance. • I learned how to systematically narrow the differential diagnosis list in patients with mixed presentations. • I remembered how important it is to think outside the box and view each case as a mystery to be solved with tools, skills, and previous experience.
Keynote speaker Helen Danesh-Meyer, MD, PhD
Louis Pasquale makes the case for redefining the term, primary open-angle glaucoma, at AAO Louis Pasquale, MD, the 2016 American Glaucoma Society Subspecialty Day Lecturer at the American Academy of Ophthalmology annual meeting, suggested that the term “primary openangle glaucoma” (POAG) be redefined to more accurately describe the disease. According to Dr. Pasquale, POAG may actually be several diseases, and stratifying the condition into different subtypes, each with associated risk factors, could help optimize patient care.
Watch the interview https://www.aao.org/interview/primary-open-angle-glaucoma-redefined
4
EYE WITNESS #33